Gossamer Bio, Inc.

GOSS • NASDAQ • Stock Fundamentals

Gossamer Bio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Faheem Hasnain, with a market cap of $51.6M.

Market Cap$51.6M

Employees135.0

CEOFaheem Hasnain

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 18, 2026 · 10 days agoQ1 2026

Next EarningsAug 4, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Gossamer Bio, Inc.

Gossamer Bio, Inc. (GOSS) has a market capitalization of $51.6M and trades on NASDAQ.

Gossamer Bio, Inc. has approximately 135 employees.